Bio-Works Technologies First Quarter 2025 Earnings: kr0.10 loss per share (vs kr0.30 loss in 1Q 2024)

Bio-Works Technologies (NGM:BIOWKS) First Quarter 2025 Results

Key Financial Results

• Revenue: kr9.09m (up 35% from 1Q 2024).
• Net loss: kr7.98m (loss narrowed by 33% from 1Q 2024).
• kr0.10 loss per share (improved from kr0.30 loss in 1Q 2024).

We've discovered 6 warning signs about Bio-Works Technologies. View them for free.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Bio-Works Technologies shares are up 7.9% from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 6 warning signs for Bio-Works Technologies you should be aware of, and 3 of them are concerning.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.